Paul Baas, MD, PhD, discusses the benefits of immunotherapy in subpopulations of patients with mesothelioma.
Paul Baas, MD, PhD
Advertisement
Articles by Paul Baas, MD, PhD
Paul Baas, MD, PhD, discusses recent updates in immuno-oncology within the field of mesothelioma.
Dr. Paul Baas from the Netherlands Cancer Institute on the Standard of Care for Mesothelioma Patients
Advertisement
Latest Updated Articles
Dr. Baas on the Promise of Immuno-Oncology in MesotheliomaPublished: July 24th 2020 | Updated:
Dr. Baas on the Standard of Care for Mesothelioma PatientsPublished: September 6th 2011 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
3
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
4
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
5